Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: clinical trial.

Raul C Verdin-Vasquez1, Carlos Zepeda-Perez, Rolando Ferra-Ferrer

  • 1Cardiothoracic Surgery Department, Hospital Centro Medico La Raza, Mexico City, Mexico.

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|July 5, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema.

Allergy·2026
Same author

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis.

Lupus science & medicine·2025
Same author

Dyslipidemia: recommendations for diagnosis and treatment at the first level of medical contact.

Gaceta medica de Mexico·2025
Same author

Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.

Archivos de cardiologia de Mexico·2024
Same author

Real-world experience of hereditary angioedema (HAE) in Mexico: A mixed-methods approach to describe epidemiology, diagnosis, and treatment patterns.

The World Allergy Organization journal·2023
Same author

Dried Serum Samples for Antibody Detection in Arthropod-Borne Virus Infections Are an Effective Alternative to Serum Samples.

The American journal of tropical medicine and hygiene·2023

Perfluorocarbon emulsions (PFC) like Perftoran can safely transport oxygen, potentially replacing blood transfusions in surgery. This study found Perftoran reduced red blood cell needs in cardiac patients without complications.

Area of Science:

  • Biomedical Engineering
  • Anesthesiology
  • Cardiovascular Surgery

Background:

  • Perfluorocarbon emulsions (PFCs) offer oxygen transport capabilities.
  • PFCs are explored as alternatives to allogeneic blood transfusions in surgical settings.
  • Ensuring adequate oxygenation is critical during cardiac procedures.

Purpose of the Study:

  • To evaluate the safety and efficacy of Perftoran, a PFC, in cardiac surgery.
  • To determine if Perftoran reduces the need for allogeneic red blood cell transfusions.
  • To assess intraoperative oxygenation levels in patients receiving Perftoran.

Main Methods:

  • A randomized clinical trial involving 30 patients undergoing elective cardiac valvuloplasty.
  • Patients received either Perftoran (PFC group, n=15) or standard care (Control group, n=15).

Related Experiment Videos

  • Procedures included preoperative acute normovolemic hemodilution and 1.0 FI02.

    • Main Results:

    • The Perftoran group exhibited significantly higher intraoperative PaO2 levels.
    • Patients in the PFC group required fewer allogeneic red blood cell packs compared to the control group.
    • No complications or deaths were reported in either the Perftoran or Control groups.

    Conclusions:

    • Perftoran demonstrates safety and efficacy as an oxygen-carrying agent in cardiac surgery.
    • Perftoran effectively reduces the requirement for allogeneic blood and blood products.
    • This PFC offers a promising alternative to traditional blood transfusions for selected surgical patients.